FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Fair John A 2. Date of Event Requiring Statement (MM/DD/YYYY)
3/6/2020 

3. Issuer Name and Ticker or Trading Symbol Dare Bioscience, Inc. [DARE]
(Last)       (First)       (Middle)
3655 NOBEL DRIVE, SUITE 260
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Strategy Officer /
(Street)
SAN DIEGO, CA 92122      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   (1) 9/7/2028  Common stock  150000.0  $1.01  D   
Employee Stock Option (right to buy)   (2) 1/29/2029  Common stock  75000.0  $0.76  D   

Explanation of Responses:
(1)  This stock option was granted to the reporting person on September 7, 2018 and vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.
(2)  This stock option was granted to the reporting person on January 29, 2019 and vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Fair John A
3655 NOBEL DRIVE
SUITE 260
SAN DIEGO, CA 92122


Chief Strategy Officer

Signatures
/s/ John Fair 3/9/2020
**Signature of Reporting Person Date
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Dare Bioscience Charts.
Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Dare Bioscience Charts.